These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22190574)

  • 1. HCV core and NS3 proteins manipulate human blood-derived dendritic cell development and promote Th 17 differentiation.
    Tu Z; Hamalainen-Laanaya HK; Nishitani C; Kuroki Y; Crispe IN; Orloff MS
    Int Immunol; 2012 Feb; 24(2):97-106. PubMed ID: 22190574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human dendritic cells expressing hepatitis C virus core protein display transcriptional and functional changes consistent with maturation.
    Landi A; Yu H; Babiuk LA; van Drunen Littel-van den Hurk S
    J Viral Hepat; 2011 Oct; 18(10):700-13. PubMed ID: 20701679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile.
    Gelderblom HC; Nijhuis LE; de Jong EC; te Velde AA; Pajkrt D; Reesink HW; Beld MG; van Deventer SJ; Jansen PL
    Liver Int; 2007 Sep; 27(7):944-53. PubMed ID: 17696933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulation by hepatitis C virus-derived proteins: targeting human dendritic cells by multiple mechanisms.
    Krishnadas DK; Ahn JS; Han J; Kumar R; Agrawal B
    Int Immunol; 2010 Jun; 22(6):491-502. PubMed ID: 20410260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subversion of plasmacytoid and myeloid dendritic cell functions in chronic HCV infection.
    Szabo G; Dolganiuc A
    Immunobiology; 2005; 210(2-4):237-47. PubMed ID: 16164031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation.
    Dolganiuc A; Kodys K; Kopasz A; Marshall C; Do T; Romics L; Mandrekar P; Zapp M; Szabo G
    J Immunol; 2003 Jun; 170(11):5615-24. PubMed ID: 12759441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activation and differentiation of naïve CD4+ and CD8+ T cells into HCV core- and NS3-specific armed effector cells: a new role for CD4+ T cells.
    Krishnadas DK; Li W; Kumar R; Tyrrell LJ; Agrawal B
    Cell Immunol; 2009; 259(2):141-9. PubMed ID: 19616202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes.
    Brady MT; MacDonald AJ; Rowan AG; Mills KH
    Eur J Immunol; 2003 Dec; 33(12):3448-57. PubMed ID: 14635055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus structural proteins do not prevent human dendritic cell maturation.
    Thumann C; Schvoerer E; Abraham JD; Bohbot A; Stoll-Keller F; Aubertin AM; Kieny MP
    Gastroenterol Clin Biol; 2008 Jan; 32(1 Pt. 1):59-68. PubMed ID: 18341978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocytes transduced with lentiviral vectors expressing hepatitis C virus non-structural proteins and differentiated into dendritic cells stimulate multi-antigenic CD8(+) T cell responses.
    Jirmo AC; Koya RC; Sundarasetty BS; Pincha M; Yu GY; Lai M; Bakshi R; Schlaphoff V; Grabowski J; Behrens G; Wedemeyer H; Stripecke R
    Vaccine; 2010 Jan; 28(4):922-33. PubMed ID: 19931383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells.
    Echeverria I; Pereboev A; Silva L; Zabaleta A; Riezu-Boj JI; Bes M; Cubero M; Borras-Cuesta F; Lasarte JJ; Esteban JI; Prieto J; Sarobe P
    Hepatology; 2011 Jul; 54(1):28-37. PubMed ID: 21452282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C).
    Echeverría I; Zabaleta A; Silva L; Díaz-Valdés N; Riezu-Boj JI; Lasarte JJ; Borrás-Cuesta F; Civeira MP; Prieto J; Sarobe P
    J Viral Hepat; 2008 Nov; 15(11):782-9. PubMed ID: 18637068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus core protein induces homotolerance and cross-tolerance to Toll-like receptor ligands by activation of Toll-like receptor 2.
    Chung H; Watanabe T; Kudo M; Chiba T
    J Infect Dis; 2010 Sep; 202(6):853-61. PubMed ID: 20677943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular immune responses and occult infection in seronegative heterosexual partners of chronic hepatitis C patients.
    Roque-Cuéllar MC; Sánchez B; García-Lozano JR; Praena-Fernández JM; Núñez-Roldán A; Aguilar-Reina J
    J Viral Hepat; 2011 Oct; 18(10):e541-9. PubMed ID: 21914075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCV-specific T-cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance.
    Ruys TA; Nanlohy NM; van den Berg CH; Hassink E; Beld M; van de Laar T; Bruisten S; Wit F; Krol A; Prins M; Lange J; van Baarle D
    J Viral Hepat; 2008 Jun; 15(6):409-20. PubMed ID: 18221302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
    Raziorrouh B; Ulsenheimer A; Schraut W; Heeg M; Kurktschiev P; Zachoval R; Jung MC; Thimme R; Neumann-Haefelin C; Horster S; Wächtler M; Spannagl M; Haas J; Diepolder HM; Grüner NH
    Gastroenterology; 2011 Oct; 141(4):1422-31, 1431.e1-6. PubMed ID: 21763239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins.
    Chang S; Dolganiuc A; Szabo G
    J Leukoc Biol; 2007 Sep; 82(3):479-87. PubMed ID: 17595379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model.
    El-Gogo S; Staib C; Lasarte JJ; Sutter G; Adler H
    J Gene Med; 2008 Feb; 10(2):177-86. PubMed ID: 18076128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.